Assignee
HEPAGENE THERAPEUTICS HK LTD
HK·4 granted patents·9 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
13 records- 0158US2021079006A1Nitrogen-containing heterocyclic compounds as fxr modulatorsHEPAGENE THERAPEUTICS HK LTD·Filed 2020·Application pending·0 cites
- 0256US10919903B2Nitrogen-containing heterocyclic compounds as FXR modulatorsHEPAGENE THERAPEUTICS HK LTD·Filed 2017·Granted Feb 16, 2021·0 cites·33 claims
- 0356US2024392289A1Ligand conjugates for delivery of therapeutically active agentsHEPAGENE THERAPEUTICS HK LTD·Filed 2022·Application pending·0 cites
- 0456US2025066346A1Solid forms of a benzthiazole-piperazinyl-oxazole compound and methods of use thereofHEPAGENE THERAPEUTICS HK LTD·Filed 2023·Application pending·0 cites
- 0552US12378268B2Heterocyclic THR-β receptor agonist compound and preparation method and use thereforHEPAGENE THERAPEUTICS HK LTD·Filed 2020·Granted Aug 5, 2025·0 cites·24 claims
- 0652US2024382471A1Glucagon-like peptide-1 receptor modulators and uses thereofHEPAGENE THERAPEUTICS HK LTD·Filed 2022·Application pending·0 cites
- 0751US2024246978A1Phenyldihydropyrimidine compound and use thereofHEPAGENE THERAPEUTICS HK LTD·Filed 2022·Application pending·0 cites
- 0848US2024092799A1Mnk inhibitorsHEPAGENE THERAPEUTICS HK LTD·Filed 2021·Application pending·0 cites
- 0947US2022220152A1Bivalent antagonists of inhibitors of apoptosis proteinsHEPAGENE THERAPEUTICS HK LTD·Filed 2020·Application pending·0 cites
- 1045US11427556B2Urea derivatives as inhibitors of ASK1HEPAGENE THERAPEUTICS HK LTD·Filed 2018·Granted Aug 30, 2022·0 cites·18 claims
- 1142US2021371459A1Dimeric peptide inhibitors of apoptosis proteinsHEPAGENE THERAPEUTICS HK LTD·Filed 2018·Application pending·0 cites
- 1241US2021179600A1Oxazole and thiazole derivatives as inhibitors of ask1HEPAGENE THERAPEUTICS HK LTD·Filed 2018·Application pending·0 cites
- 1340US10899723B2Heterocyclic containing cyclopropyl FXR modulatorsHEPAGENE THERAPEUTICS HK LTD·Filed 2017·Granted Jan 26, 2021·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when HEPAGENE THERAPEUTICS HK LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →